Plexus (PLXS) Projected to Release Earnings on Wednesday

Plexus (NASDAQ:PLXS) is anticipated to release its Q4 2026 results after the market closes on Wednesday, October 28th. Analysts expect Plexus to post earnings of $2.55 per share and revenue of $1.36 billion for the quarter. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Interested persons can check the company’s upcoming Q4 2026 earnings summary page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:30 AM ET.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating the consensus estimate of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%. The business had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the previous year, the business earned $1.64 earnings per share. The business’s revenue was up 28.2% on a year-over-year basis. On average, analysts expect Plexus to post $7.13 EPS for the current fiscal year and $8.55 EPS for the next fiscal year.

Plexus Stock Performance

NASDAQ:PLXS opened at $216.98 on Monday. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06. Plexus has a 12-month low of $132.03 and a 12-month high of $307.06. The stock has a 50-day moving average price of $249.62 and a 200 day moving average price of $258.70. The stock has a market capitalization of $5.81 billion, a P/E ratio of 32.00 and a beta of 0.88.

Analysts Set New Price Targets

PLXS has been the subject of several recent analyst reports. Needham & Company LLC restated a “buy” rating and issued a $310.00 price target on shares of Plexus in a research note on Friday, August 14th. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a research report on Friday, July 31st. KeyCorp upgraded shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective on the stock in a research report on Monday, September 21st. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $276.86.

Insider Activity

In other news, Director Karen Rapp sold 500 shares of Plexus stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the sale, the director directly owned 7,535 shares of the company’s stock, valued at approximately $1,814,955.45. The trade was a 6.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the completion of the sale, the chief executive officer directly owned 65,888 shares in the company, valued at $16,536,570.24. This trade represents a 2.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 9,000 shares of company stock worth $2,319,260 over the last 90 days. Corporate insiders own 1.78% of the company’s stock.

Plexus Company Profile

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.